209 related articles for article (PubMed ID: 7569672)
1. Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies.
Dahlem AM; Allerheiligen SR; Vodicnik MJ
Toxicol Pathol; 1995; 23(2):170-8. PubMed ID: 7569672
[TBL] [Abstract][Full Text] [Related]
2. Toxicology in the drug discovery and development process.
Dorato MA; Buckley LA
Curr Protoc Pharmacol; 2006 Apr; Chapter 10():Unit10.3. PubMed ID: 22294168
[TBL] [Abstract][Full Text] [Related]
3. Differences between pharmacokinetics and toxicokinetics.
Welling PG
Toxicol Pathol; 1995; 23(2):143-7. PubMed ID: 7569668
[TBL] [Abstract][Full Text] [Related]
4. The application of capillary microsampling in GLP toxicology studies.
Verhaeghe T; Dillen L; Stieltjes H; Zwart L; Feyen B; Diels L; Vroman A; Timmerman P
Bioanalysis; 2017 Apr; 9(7):531-540. PubMed ID: 28300424
[TBL] [Abstract][Full Text] [Related]
5. Principles and practices of integrating genotoxicity evaluation into routine toxicology studies: a pharmaceutical industry perspective.
Krishna G; Urda G; Theiss J
Environ Mol Mutagen; 1998; 32(2):115-20. PubMed ID: 9776173
[TBL] [Abstract][Full Text] [Related]
6. Toxicokinetics in the evaluation of toxicity data.
Watanabe PG; Schumann AM; Reitz RH
Regul Toxicol Pharmacol; 1988 Dec; 8(4):408-13. PubMed ID: 3222482
[TBL] [Abstract][Full Text] [Related]
7. Study design and statistical analysis of toxicokinetics: a report of JPMA investigation of case studies.
Igarashi T; Yabe T; Noda K
J Toxicol Sci; 1996 Dec; 21(5):497-504. PubMed ID: 9035061
[TBL] [Abstract][Full Text] [Related]
8. Toxicokinetics in preclinical evaluation.
Baldrick P
Drug Discov Today; 2003 Feb; 8(3):127-33. PubMed ID: 12568782
[TBL] [Abstract][Full Text] [Related]
9. Toxicokinetics in the National Toxicology Program.
Goehl TJ
NIDA Res Monogr; 1997; 173():273-304. PubMed ID: 9260193
[TBL] [Abstract][Full Text] [Related]
10. Providing toxicokinetic support for reproductive toxicology studies in pharmaceutical development.
Schwartz S
Arch Toxicol; 2001 Sep; 75(7):381-7. PubMed ID: 11693177
[TBL] [Abstract][Full Text] [Related]
11. Dose selection for toxicity studies: a protocol for determining the maximum repeatable dose.
Spurling NW; Carey PF
Hum Exp Toxicol; 1992 Nov; 11(6):449-57. PubMed ID: 1361132
[TBL] [Abstract][Full Text] [Related]
12. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
Dixit R; Riviere J; Krishnan K; Andersen ME
J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
[TBL] [Abstract][Full Text] [Related]
13. Sparse sampling for assessment of drug exposure in toxicological studies.
Burtin P; Mentre F; van Bree J; Steimer JL
Eur J Drug Metab Pharmacokinet; 1996; 21(2):105-11. PubMed ID: 8839683
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies.
Chapman K; Chivers S; Gliddon D; Mitchell D; Robinson S; Sangster T; Sparrow S; Spooner N; Wilson A
Drug Discov Today; 2014 May; 19(5):528-32. PubMed ID: 24448068
[TBL] [Abstract][Full Text] [Related]
15. Issues related to the use of canines in toxicologic pathology--issues with pharmacokinetics and metabolism.
Tibbitts J
Toxicol Pathol; 2003; 31 Suppl():17-24. PubMed ID: 12597427
[TBL] [Abstract][Full Text] [Related]
16. Interspecies scaling and comparisons in drug development and toxicokinetics.
Ings RM
Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
[TBL] [Abstract][Full Text] [Related]
17. Framework for gender differences in human and animal toxicology.
Gochfeld M
Environ Res; 2007 May; 104(1):4-21. PubMed ID: 16616135
[TBL] [Abstract][Full Text] [Related]
18. Auditing drug metabolism protocols, data, and reports.
Lucas G; Walls S
Qual Assur; 1994 Jun; 3(2):193-7. PubMed ID: 7804636
[TBL] [Abstract][Full Text] [Related]
19. The application of toxicokinetic data to dosage selection in toxicology studies.
Morgan DG; Kelvin AS; Kinter LB; Fish CJ; Kerns WD; Rhodes G
Toxicol Pathol; 1994; 22(2):112-23. PubMed ID: 7973359
[TBL] [Abstract][Full Text] [Related]
20. Drug toxicokinetics: scope and limitations that arise from species differences in pharmacodynamic and carcinogenic responses.
Monro A
J Pharmacokinet Biopharm; 1994 Feb; 22(1):41-57. PubMed ID: 8027948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
